-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UTlww6UObnu1Mhw4iQ2CRx7mMvStiVLGYKwkyptuzh922W1/vzAZ69T2fwuBPXFN hVOxk+tOAg9bMNrXKm5jAw== 0000932440-01-000054.txt : 20010213 0000932440-01-000054.hdr.sgml : 20010213 ACCESSION NUMBER: 0000932440-01-000054 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LYNX THERAPEUTICS INC CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-45671 FILM NUMBER: 1534795 BUSINESS ADDRESS: STREET 1: 3832 BAY CENTER PL CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW YORK LIFE INSURANCE CO CENTRAL INDEX KEY: 0000071633 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 135582869 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 51 MADISON AVE ROOM 207 STREET 2: ATTN INVESTMENT DEPT VENTURE CAP GROUP CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 2125766806 MAIL ADDRESS: STREET 1: 51 MADISON AVE ROOM 207 STREET 2: ATTN INVESTMENT DEPT VENTURE CAP GROUP CITY: NEW YORK STATE: NY ZIP: 10010 SC 13G/A 1 0001.txt SCHEDULE 13G - AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* ** LYNX THERAPEUTICS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 551812308 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). **This Amendment No. 1 is the Final and Terminating Amendment. SCHEDULE 13G CUSIP NO. 379904 10 5 PAGE 2 OF 4 PAGES LYNX THERAPEUTICS, INC. 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON NEW YORK LIFE INSURANCE COMPANY 13-5582869 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NEW YORK NUMBER OF 5. SOLE VOTING POWER 24,000 SHARES BENEFICIALLY 6. SHARED VOTING POWER 0 OWNED BY EACH 7. SOLE DISPOSITIVE POWER 24,000 REPORTING PERSON 8. SHARED DISPOSITIVE POWER 0 WITH 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 24,000 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 .0021% 12. TYPE OF REPORTING PERSON* IC *SEE INSTRUCTIONS BEFORE FILLING OUT SCHEDULE 13G CUSIP NO. 379904 10 5 PAGE 3 OF 4 PAGES LYNX THERAPEUTICS, INC. Item 1(a) Name of Issuer: LYNX THERAPEUTICS, INC. Item 1(b) Address of Issuer's principal executive offices: 25861 INDUSTRIAL BOULEVARD HAYWARD, CA 94545 Item 2(a) Name of person filing: NEW YORK LIFE INSURANCE COMPANY Item 2(b) Address of principal business office: 51 MADISON AVENUE, ROOM 206 NEW YORK, NY 10010 Item 2(c) Citizenship: NEW YORK Item 2(d) Title of class of securities: COMMON STOCK Item 2(e) Cusip No.: 551812308 Item 3 Type of Person: INSURANCE COMPANY AS DEFINED IN SECTION 3(A)(19) OF THE ACT Item 4(a) Amount beneficially owned: Item 4(b) Percent of class: .0021% Item 4(c) (i) sole power to vote: 24,000 (ii)shared power to vote: 0 (iii) sole power to dispose: 24,000 (iv)shared power to dispose: 0 Item 5 Ownership of 5 percent or less of a class: ORIGINAL 13G FILED ON FEBRUARY 16, 1996 WAS FILED IN ERROR. NEW YORK LIFE INSURANCE COMPANY DID NOT HAVE OWNERSHIP OF MORE THAN 5% AT THAT TIME. IF THIS STATEMENT IS BEING FILED TO REPORT THE FACT THAT AS OF THE DATE HEREOF THE REPORTING PERSON HAS CEASED TO BE THE BENEFICIAL OWNER OF MORE THAN FIVE PERCENT OF THE CLASS SECURITIES, CHECK THE FOLLOWING (X). Item 6 Ownership of more than 5 percent on behalf of another person: NOT APPLICABLE Item 7 Identification and classification of subsidiary: NOT APPLICABLE SCHEDULE 13G CUSIP NO. 379904 10 5 PAGE 4 OF 4 PAGES LYNX THERAPEUTICS, INC. Item 8 Identification and classification of members of the group: NOT APPLICABLE Item 9 Notice of dissolution of the group: NOT APPLICABLE Item 10 Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Dated: February 9, 2001 NEW YORK LIFE INSURANCE COMPANY By: /s/ William Y. Cheng ------------------------------- Name: William Y. Cheng Title: Vice President -----END PRIVACY-ENHANCED MESSAGE-----